Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125543 | 0.80 | ALDH1A3 (0.64) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL9111062 | 0.78 | ALDH1A3 (0.53) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL15780502 | 0.77 | ACACB (0.38) | ALDH1A1TP53MAPK1TSHRHIF1A | |
| SCHEMBL5501717 | 0.76 | P2RY6 (0.48) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL14607276 | 0.75 | KMT2A (0.49) | KMT2APOLBALDH1A1TSHRHSD17B10 | |
| Hydrogen Peroxide SCHEMBL28902806 | 0.75 | KMT2A (0.70) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL18836850 | 0.74 | PARP10 (0.46) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL1805832 | 0.73 | ALDH1A3 (0.58) | ALDH1A3KMT2APARP10POLBGLA | |
| SCHEMBL156005 | 0.73 | CA1 (0.58) | KMT2AALDH1A1TP53MAPK1TSHR | |
| SCHEMBL6138149 | 0.72 | HTR3E (0.62) | PARP10POLBGLASCN5ASCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066133-A1 | THERAPEUTIC AGENTS AND CONJUGATES THEREOF | AJ SCIENCES (YIXING) CO., LTD (CN) | 2024-02-29 | — | — | US | disclosed |
| US-11572398-B2 | GLP-1 derivatives and uses thereof | NOVO NORDISK A/S (DK) | 2023-02-07 | — | — | US | disclosed |
| US-20210332082-A1 | TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION | Belyntic GmbH (DE) | 2021-10-28 | — | — | US | disclosed |
| US-20210206799-A1 | LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES | Belyntic GmbH (DE) | 2021-07-08 | — | — | US | disclosed |
| US-10954266-B2 | Linker molecule and use thereof in methods for purifying peptides | Belyntic GmbH (DE) | 2021-03-23 | — | — | US | disclosed |
| US-20190309013-A1 | LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES | Belyntic GmbH (DE) | 2019-10-10 | — | — | US | disclosed |
| US-20170320927-A1 | GLP-1 Derivatives and Uses Thereof | NOVO NORDISK A/S (DK) | 2017-11-09 | — | — | US | disclosed |
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190309013-A1 | LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES | SPPL2B, VIP, SPPL2A | ALDH1A3 3716/4885KMT2A 3459/4885PARP10 764/4885 |
| US-20210332082-A1 | TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION | VIP, NGLY1, HM13 | ALDH1A3 3512/4885KMT2A 2344/4885PARP10 3367/4885 |
| US-20210206799-A1 | LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES | SPPL2B, SPPL2A, VIP | ALDH1A3 4008/4885KMT2A 2761/4885PARP10 771/4885 |
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | CPN1, HAT1, PRSS1 | ALDH1A3 3419/4885KMT2A 1478/4885PARP10 2057/4885 |
| US-11572398-B2 | GLP-1 derivatives and uses thereof | GLP1R, GIPR, GCG | ALDH1A3 4153/4885KMT2A 4053/4885PARP10 3168/4885 |
| US-20170320927-A1 | GLP-1 Derivatives and Uses Thereof | GLP1R, GIPR, GCG | ALDH1A3 4153/4885KMT2A 4053/4885PARP10 3168/4885 |
| US-20240066133-A1 | THERAPEUTIC AGENTS AND CONJUGATES THEREOF | TLR9, STING1, TLR3 | ALDH1A3 4735/4885KMT2A 812/4885PARP10 685/4885 |
| US-10954266-B2 | Linker molecule and use thereof in methods for purifying peptides | SPPL2B, VIP, SPPL2A | ALDH1A3 3716/4885KMT2A 3459/4885PARP10 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.